Lsv Asset Management Collegium Pharmaceutical, Inc Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

A detailed history of Lsv Asset Management transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Lsv Asset Management holds 451,251 shares of COLL stock, worth $13.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

451,251

Previous 380,551 18.58%

Holding current value

$13.1 Million

Previous $12.3 Million 42.29%

% of portfolio

0.04%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.4 - $39.07 $2.22 Million - $2.76 Million	70,700 Added 18.58%	451,251 $17.4 Million
Q1 2024 May 06, 2024	BUY	$31.23 - $40.91 $7.77 Million - $10.2 Million	248,751 Added 188.73%	380,551 $14.8 Million
Q4 2023 Feb 06, 2024	BUY	$21.16 - $30.8 $1.2 Million - $1.74 Million	56,500 Added 75.03%	131,800 $4.06 Million
Q3 2023 Nov 03, 2023	SELL	$21.23 - $24.28 $4.15 Million - $4.74 Million	-195,300 Reduced 72.17%	75,300 $1.68 Million
Q2 2023 Aug 02, 2023	BUY	$21.06 - $24.0 $627,588 - $715,200	29,800 Added 12.38%	270,600 $5.82 Million
Q1 2023 May 02, 2023	BUY	$23.0 - $29.88 $71,300 - $92,628	3,100 Added 1.3%	240,800 $5.78 Million
Q4 2022 Feb 08, 2023	SELL	$16.14 - $23.55 $30,666 - $44,745	-1,900 Reduced 0.79%	237,700 $5.52 Million
Q3 2022 Nov 07, 2022	SELL	$15.46 - $20.1 $1.82 Million - $2.37 Million	-117,900 Reduced 32.98%	239,600 $3.84 Million
Q2 2022 Aug 10, 2022	SELL	$14.22 - $20.88 $35,550 - $52,200	-2,500 Reduced 0.69%	357,500 $6.34 Million
Q1 2022 May 12, 2022	SELL	$17.2 - $22.5 $30,960 - $40,500	-1,800 Reduced 0.5%	360,000 $7.33 Million
Q4 2021 Jan 28, 2022	BUY	$17.5 - $21.35 $3.76 Million - $4.59 Million	214,900 Added 146.29%	361,800 $6.76 Million
Q3 2021 Nov 04, 2021	BUY	$17.75 - $25.39 $2.61 Million - $3.73 Million	146,900 New	146,900 $2.9 Million

Others Institutions Holding COLL

# of Institutions

255

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $992M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Collegium Pharmaceutical, Inc Transaction History